Abstract P1-19-04: Results from Plasmamatch Trial Treatment Cohort A: A Phase II Trial of Extended-Dose Fulvestrant in Patients with an ESR1 Mutation Identified Via Ctdna Screening (CRUK/15/010)
Cancer Research(2020)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要